Position in XERS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,804,100
+$7,093,744 QoQ
Shares Held
1,742,942
+50.6% QoQ
Ownership
0.956%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#16
of 238 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ALGERT GLOBAL LLC holds $59,184,383 across 9 Drug Manufacturers - Specialty & Generic names. XERS ranks #2 (23.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
191,841 | $15,295,482 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
1,742,942 | $13,804,100 | |
| 3 | VTRS |
Viatris Inc
|
727,900 | $11,559,052 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
151,208 | $4,747,931 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
180,430 | $4,440,382 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
91,070 | $4,235,665 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
131,400 | $2,651,652 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
63,470 | $2,200,504 |
All Filings in XERS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,804,100 | 1,742,942 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,710,356 | 1,156,958 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,642,925 | 718,844 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,285,794 | 157,960 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||